Nomura, Hisanaga http://orcid.org/0000-0002-0744-7425
Tsuji, Daiki
Ueno, Shohei
Kojima, Takashi
Fujii, Satoshi
Yano, Tomonori
Daiko, Hiroyuki
Demachi, Ken
Itoh, Kunihiko
Kawasaki, Toshikatsu
Article History
Received: 13 October 2021
Accepted: 12 November 2021
First Online: 18 November 2021
Declarations
:
: The study protocol was approved by the institutional review board of the NCC, Japan in March 2017 (2016–384). These patients were consented to be used the clinical information and DNA sample in the National Cancer Center (NCC) Biobank Registry. The study design is displayed on the website for the National Cancer Center Hospital East, providing the relatives of deceased patients the opportunity to decline participation in the current study.
: All authors agree to publish.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All patients provided their written informed consent to allow the use of their clinical information and DNA samples, which are available in the NCC Biobank Registry.
: Takashi Kojima received honoraria from Ono and MSD and research funding from Ono, MSD, Taiho, Chugai, Shionogi and Palexel. Tomoaki Yano received honoraria from Olympus, Meijiseika pharma and research funding from Olympus, Fujifirm, HOYA PENTAX, Rakuten Medical, SHIMADZU and Tokyo Giken. All other authors declare no potential conflicts of interest.